Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 213-218

  Zhang, Zhenwen ^a   Sheng, Shudong ^b   Guo, Lili ^c   Li, Guangzhi ^a   Zhang, Ling ^a   Zhang, Linxiang ^a   Shi, Mingyi ^a   Bo, Ping ^a   Zhu, Yan ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Yangzhou Vocational College of Environment and Resources   (China)

^c Chuzhou College   (China)

Author keywords

GLUT4; Insulin sensitivity; Intracerebroventricular injection

Indexed keywords

GALANIN; GALANIN ANTAGONIST; GALANIN RECEPTOR; GLUCOSE TRANSPORTER 4; M 35; MESSENGER RNA; OPIATE AGONIST; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EPIDIDYMIS; GENE EXPRESSION; GLUCOSE INFUSION; GLUCOSE TRANSPORT; HYPOTHALAMUS; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRADYKININ; CELL MEMBRANE; CHOLESTEROL; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GALANIN; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; INSULIN; INSULIN RESISTANCE; MALE; PEPTIDE FRAGMENTS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RNA, MESSENGER; TRIGLYCERIDES;

EID: 84864371656     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.04.012     Document Type: Article

References (33)

1. Adams A.C., Clapham J.C., Wynick D., Speakman J.R. Feeding behaviour in GAL knockout mice supports a role of galanin in fat intake and preference. J. Neuroendocrinol. 2008, 20:199-206.
2. Ahren B., Pacini G., Wynick D., Wierup N., Sundler F. Loss of function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 2004, 145:3190-3196.
3. Atalik K.E., Okudan N., Gokbel H., Kalkan S., Cuce G. Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J. Smooth Muscle Res. 2010, 46:175-183.
4. Bonen A., Dohm G.L., van Loon L.J. Lipid metabolism, exercise and insulin action. Essays Biochem. 2006, 42:47-59.
5. Ciosek J., Cisowska A. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats. J. Physiol. Pharmacol. 2003, 54:625-641.
6. Díaz-Cabiale Z., Parrado C., Rivera A., de la Calle A., Agnati L., Fuxe K., Narváez J.A. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Neuropharmacology 2007, 52:684-692.
7. Geiger P.C., Han D.H., Wright D.C., Holloszy J.O. How muscle insulin sensitivity is regulated: testing of a hypothesis. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1258-E1263.
8. Guo L., Shi M., Zhang L., Li G., Zhang L., Shao H., Li J., Fang P., Ma Y., Shi Q., Sui Y. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats. Gen. Comp. Endocrinol. 2011, 173:159-163.
9. Hajhashemi V., Sadeghi H., Minaiyan M., Movahedian A., Talebi A. The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in rats. Clinics 2010, 65:1183-1187.
10. He B., Shi M., Zhang L., Li G., Zhang L., Shao H., Li J., Fang P., Ma Y., Shi Q., Sui Y. Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats. Physiol. Behav. 2011, 103:284-289.
11. Holmes P.V., Yoo H.S., Dishman R.K. Voluntary exercise and clomipramine treatment elevate prepro-galanin mRNA levels in the locus coeruleus in rats. Neurosci. Lett. 2006, 408:1-4.
12. Kyrkouli S.E., Strubbe J.H., Scheurink A.J. Galanin in the PVN increases nutrient intake and changes peripheral hormone levels in the rat. Physiol. Behav. 2006, 89:103-109.
13. Lahaye Sle D., Gratas-Delamarche A., Malardé L., Vincent S., Zguira M.S., Morel S.L., Delamarche P., Zouhal H., Carré F., Bekono F.R. Intense exercise training induces adaptation in expression and responsiveness of cardiac β-adrenoceptors in diabetic rats. Cardiovasc. Diabetol. 2010, 9:72-77.
14. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115:177-207.
15. Legalkis I.N. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Drug News Perspect. 2005, 18:173-177.
16. Legalkis I.N., Mantzouridis T., Mountokalakis T. Positive correlation of galanin with glucose in healthy volunteers during an oral glucose tolerance test. Horm. Metab. Res. 2007, 39:53-55.
17. Leibowitz S.F. Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides 2005, 39:327-332.
18. Leney S.E., Tavaré J.M. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J. Endocrinol. 2009, 203:1-18.
19. Liang Y., Sheng S.D., Fang P.H., Ma Y.P., Li J., Shi Q.J., Sui Y.M., Shi M.Y. Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats. Pharmacol. Biochem. Behav. 2012, 100:554-559.
20. Lu X., Barr A.M., Kinney J.W., Sanna P., Conti B., Behrens M.M., Bartfai T. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc. Natl. Acad. Sci. USA 2005, 102:874-879.
21. Murray P.S., Groves J.L., Pettett B.J., Britton S.L., Koch L.G., Dishman R.K., Holmes P.V. Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity. Peptides 2010, 31:2264-2268.
22. Ogren S.O., Razani H., Elvander-Tottie E., Kehr J. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders. Physiol. Behav. 2007, 92:172-179.
23. Poritsanos N.J., Mizuno T.M., Lautatzis M.-E., Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int. J. Obes. 2009, 33:1381-1389.
24. Radács M., Molnár A.H., László F.A., Varga C., László F., Gálfi M. Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures. J Mol. Neurosci. 2010, 42:59-66.
25. Schött P.A., Hökfelt T., Ogren S.O. Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharmacology 2000, 39:1386-1403.
26. Shan W.F., Chen B.Q., Zhu S.J., Jiang L., Zhou Y.F. Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis. J. Zhejiang Univ. Sci. B. 2011, 12:677-682.
27. Swanson C.J., Blackburn T.P., Zhang X., Zheng K., Xu Z.Q., Hökfelt T., Wolinsky T.D., Konkel M.J., Chen H., Zhong H., Walker M.W., Craig D.A., Gerald C.P., Branchek T.A. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc. Natl. Acad. Sci. USA 2005, 102:17489-17494.
28. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 2005, 184:285-293.
29. Van Hoomissen J.D., Holmes P.V., Zellner A.S., Poudevigne A., Dishman R.K. Effects of beta-adrenoreceptor blockade during chronic exercise on contextual fear conditioning and mRNA for galanin and brain-derived neurotrophic factor. Behav. Neurosci. 2004, 118:1378-1390.
30. Vijayakumar M.V., Ajay A.K., Bhat M.K. Demonstration of a visual cell-based assay for screening glucose transporter 4 translocation modulators in real time. J. Biosci. 2010, 35:525-531.
31. Whitelaw C.M., Robinson J.E., Chambers G.B., Hastie P., Padmanabhan V., Thompson R.C., Evans N.P. Expression of mRNA for galanin, galanin-like peptide and galanin receptors 1-3 in the ovine hypothalamus and pituitary gland: effects of age and gender. Reproduction 2009, 137:141-150.
32. Yoshitake T., Yoshitake S., Savage S., Elvander-Tottie E., Ogren S.O., Kehr J. Galanin differentially regulates acetylcholine release in ventral and dorsal hippocampus: a microdialysis study in awake rat. Neuroscience 2011, 197:172-180.
33. Yun R., Dourmashkin J.T., Hill J., Gayles E.C., Fried S.K., Leibowitz S.F. PVN galanin increases fat storage and promotes obesity by causing muscle to utilize carbohydrate more than fat. Peptides 2005, 26:2265-2273.